Arthritis Drug Tocilizumab Gets FDA EUA for Severe COVID-19 Arthritis Drug Tocilizumab Gets FDA EUA for Severe COVID-19
For patients hospitalized with COVID-19, tocilizumab plus standard care has been shown to cut the risk for death, shorten hospitalization time, and reduce the need for mechanical ventilation.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news